Drägerwerk AG & Co. KGaA
Headquartered in Lübeck, Germany, and established in 1889, Drägerwerk AG & Co. KGaA is a global provider of advanced medical and safety technology solutions. The company serves a diverse international clientele across Europe, the Americas, Africa, Asia, and Australia. Within the medical field, Drägerwerk develops and…
Company description based on the data provider's company data, AI-assisted, created on 15/10/2026. Not investment advice.
1D
-1.1%
1W
-19.3%
1M
-15.0%
6M
-6.2%
YTD
+28.7%
1Y
+25.2%
2Y
+73.7%
5Y
+13.4%
10Y
+27.8%
Next earnings date
29/10/2026 (in 12 days)
Volatility around earnings
~6% weaker price swings than usual
P/E
10.47
P/B
1.08
EV/EBITDA
4.82
RETURN ON EQUITY
1.8%
NET MARGIN
3.5%
DEBT/EQUITY
0.23
DIVIDEND YIELD
2.4%
AS OF
30/06/2026
FREE FLOAT
23.4%
FLOAT SHARES
4,396,856
AVG. DAILY VOLUME (30D)
4,471
Drägerwerk AG & Co. KGaA is a company in the Healthcare sector, Medical - Devices industry, headquartered in Germany.
The CEO is Stefan A. Drager, the company employs around 16,687 people.
The IPO was on 24/06/2010; the stock trades on XETRA under the ticker DRW8.DE.
The next earnings date is 29/10/2026.
Around past earnings, price swings were roughly -6% stronger than usual.
Yes. The last dividend was €2.21 per share, ex-date 11/05/2026, paid on 13/05/2026.
The dividend yield is 2.4% (as of 30/06/2026).
Comparable stocks include Siemens Healthineers, Drägerwerk, Abbott Laboratories, Medtronic, Stryker, Boston Scientific, Edwards Lifesciences and DexCom.
Clicking "Analyze stock" lets five strategies assess Drägerwerk against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.